CEFTAZIDIME Side Effects

7022841-7 | Anaemia, Neutropenia, Pancytopenia, Thrombocytopenia
on Sep 27, 2010 Female patient from FRANCE , 80 years of age, was diagnosed with candidiasis, atrial fibrillation (What is atrial fibrillation?) and was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, neutropenia, pancytopenia, thrombocytopenia. Ceftazidime dosage: . During the same period patient was treated with VFEND (View Vfend Review and Vfend Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ).

7016625-3 | Neutropenia, Off Label Use
Patient was taking Ceftazidime (View Usage). Patient had the following side effects: neutropenia, off label use on Sep 20, 2010 from FRANCE Additional patient health information: Male patient , 18 years of age, was diagnosed with viral infection (What is viral infection?) and. Ceftazidime dosage: 10g Per Day. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM (12g Per Day) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ).

6963888-6 | Anaphylactic Reaction, No Therapeutic Response
Adverse event was reported on Aug 17, 2010 by a Female patient taking Ceftazidime (View Usage) (Dosage: 2g, Iv) was diagnosed with bronchiectasis and. Location: , 66 years of age, After Ceftazidime was administered, patient had the following side effects: anaphylactic reaction, no therapeutic response. During the same period patient was treated with ALVERINE (View Alverine Review and Alverine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), SALBUTAMOL INHALATION (View Salbutamol Inhalation Review and Salbutamol Inhalation Label ).

6963452-9 | Anaemia, Haematoma, Red Blood Cell Count Decreased
on Aug 26, 2010 Female patient from FRANCE , 63 years of age, was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haematoma, red blood cell count decreased. Ceftazidime dosage: 2g Three Times Per Day. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), PREVISCAN (View Previscan Review and Previscan Label ), AMIKIN (View Amikin Review and Amikin Label ), CLAFORAN (1g Three Times Per Day) (View Claforan Review and Claforan Label ), FLAGYL (500mg Three Times Per Day) (View Flagyl Review and Flagyl Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.


6941020-2 | Anaphylactic Reaction
on Aug 17, 2010 Female patient from UNITED KINGDOM , 66 years of age, was diagnosed with bronchiectasis, hypertension and was treated with Ceftazidime (View Usage). Patient had the following side effects: anaphylactic reaction. Ceftazidime dosage: . During the same period patient was treated with ALVERINE (360mg Per Day) (View Alverine Review and Alverine Label ), PROCHLORPERAZINE (15mg Per Day) (View Prochlorperazine Review and Prochlorperazine Label ), OMEPRAZOLE (40mg Per Day) (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (40mg Per Day) (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ).

6694771-1 | Renal Failure Acute
Patient was taking Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: renal failure acute on Apr 14, 2010 from CHINA Additional patient health information: Female patient , 41 years of age, . Ceftazidime dosage: .

6694770-X | Acute Hepatic Failure
Adverse event was reported on Apr 14, 2010 by a Male patient taking Ceftazidime (View Usage) (Dosage: ) . Location: CHINA , 65 years of age, Patient experienced the following unwanted or unexpected effects: acute hepatic failure.

6694769-3 | Asthma
on Apr 14, 2010 Female patient from CHINA , 27 years of age, was treated with Ceftazidime (View Usage). Patient had the following side effects: asthma (What is asthma?). Ceftazidime dosage: .

6694768-1 | Corneal Disorder
on Apr 14, 2010 Female patient from CHINA , 36 years of age, was treated with Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: corneal disorder. Ceftazidime dosage: .

6694767-X |
Patient was taking Ceftazidime (View Usage). on Apr 14, 2010 from CHINA Additional patient health information: Female patient , 16 years of age, . Ceftazidime dosage: .

6694766-8 | Haemolytic Anaemia
Adverse event was reported on Apr 14, 2010 by a Female patient taking Ceftazidime (View Usage) (Dosage: ) . Location: CHINA , 33 years of age, Patient had the following side effects: haemolytic anaemia.

6694765-6 | Psoriasis
on Apr 14, 2010 Female patient from CHINA , 46 years of age, was treated with Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: psoriasis. Ceftazidime dosage: .

6694764-4 | Anaphylactic Shock
on Apr 14, 2010 Female patient from CHINA , 47 years of age, was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Ceftazidime dosage: .

6694763-2 | Anaphylactic Shock
Patient was taking Ceftazidime (View Usage). Patient had the following side effects: anaphylactic shock on Apr 14, 2010 from CHINA Additional patient health information: Female patient , 67 years of age, was diagnosed with skin test and. Ceftazidime dosage: .

6655633-9 | Stevens-johnson Syndrome, Toxic Epidermal Necrolysis
Adverse event was reported on Mar 26, 2010 by a Male patient taking Ceftazidime (View Usage) (Dosage: 2 Gm Tid Iv) was diagnosed with infection (What is infection?) and. Location: UNITED STATES , 51 years of age, After Ceftazidime was administered, patient had the following side effects: stevens-johnson syndrome, toxic epidermal necrolysis. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM (3.375 Gm Qid Iv) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ). Patient was hospitalized.

6650073-0 | Erythema, Lymphocyte Stimulation Test Positive, Micturition Frequency Decreased, Pyrexia, Rash Pustular
on Mar 08, 2010 Female patient from JAPAN , 71 years of age, was diagnosed with squamous cell carcinoma and was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, lymphocyte stimulation test positive, micturition frequency decreased, pyrexia, rash pustular. Ceftazidime dosage: . During the same period patient was treated with CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ).

6546994-X | Thrombocytopenia
on Jan 14, 2010 Female patient from UNITED KINGDOM , child 9 years of age, weighting 52.69 lb, was diagnosed with cystic fibrosis and was treated with Ceftazidime (View Usage). Patient had the following side effects: thrombocytopenia. Ceftazidime dosage: . During the same period patient was treated with TAZOCIN (9mg Per Day) (View Tazocin Review and Tazocin Label ). Patient was hospitalized.

6533354-0 | Agranulocytosis, Pulmonary Thrombosis, Thrombocytopenia
Patient was taking Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: agranulocytosis, pulmonary thrombosis, thrombocytopenia on Jan 06, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, weighting 278.7 lb, was diagnosed with bronchiectasis, lung infection, chest pain (What is chest pain?) and. Ceftazidime dosage: 6g Per Day. During the same period patient was treated with GENTAMICIN (240mg Per Day) (View Gentamicin Review and Gentamicin Label ), DOXYCYCLINE (200mg Per Day) (View Doxycycline Review and Doxycycline Label ), TRAMADOL HCL (400mg Per Day) (View Tramadol Hcl Review and Tramadol Hcl Label ), IBUPROFEN (600mg Per Day) (View Ibuprofen Review and Ibuprofen Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6510123-9 | Anuria, Blood Creatinine Increased, Renal Failure Acute, Renal Tubular Necrosis
Adverse event was reported on Dec 08, 2009 by a Male patient taking Ceftazidime (View Usage) (Dosage: ) was diagnosed with cystic fibrosis, antibiotic prophylaxis, nutritional support (What is nutritional support?) and. Location: UNITED KINGDOM , child 7 years of age, Patient experienced the following unwanted or unexpected effects: anuria, blood creatinine increased, renal failure acute, renal tubular necrosis. During the same period patient was treated with GENTAMICIN (3.92mgk Three Times Per Day) (View Gentamicin Review and Gentamicin Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ), FLONASE (View Flonase Review and Flonase Label ), POTASSIUM (View Potassium Review and Potassium Label ), CREON (View Creon Review and Creon Label ), ABDEC (View Abdec Review and Abdec Label ), COLOMYCIN (View Colomycin Review and Colomycin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6461094-5 | Haematuria
on Nov 16, 2009 Male patient from CHINA , 57 years of age, was diagnosed with peritonitis and was treated with Ceftazidime (View Usage). Patient had the following side effects: haematuria. Ceftazidime dosage: 3g Twice Per Day. Patient was hospitalized.

6264378-9 | Chills, Eosinophilia, Face Oedema, Hepatic Enzyme Increased, Hypoacusis, Leukocytosis, Liver Disorder, Lymphadenopathy
on Jul 02, 2009 Male patient from SPAIN , 50 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and was treated with Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: chills, eosinophilia, face oedema, hepatic enzyme increased, hypoacusis, leukocytosis, liver disorder, lymphadenopathy. Ceftazidime dosage: 1g Three Times Per Day. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6259822-7 | Body Temperature Increased, Haemolytic Anaemia, Headache, Intravascular Haemolysis, Mental Status Changes
Patient was taking Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature increased, haemolytic anaemia, headache (What is headache?), intravascular haemolysis, mental status changes on Jul 06, 2009 from UNITED STATES Additional patient health information: Male patient , child 10 years of age, weighting 68.34 lb, was diagnosed with bacterial infection (What is bacterial infection?) and. Ceftazidime dosage: 1500 Mg Every 8 Hours Iv Bolus. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), MESNA (View Mesna Review and Mesna Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), ONDANESTRON (View Ondanestron Review and Ondanestron Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FILGASTRIM (View Filgastrim Review and Filgastrim Label ).

6243737-4 | Burning Sensation, Infusion Site Pruritus
Adverse event was reported on Jun 16, 2008 by a Female patient taking Ceftazidime (View Usage) (Dosage: 2mg Twice Per Day) was diagnosed with bronchiectasis and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: burning sensation, infusion site pruritus. During the same period patient was treated with METHADONE (View Methadone Review and Methadone Label ).

6235740-5 | Status Epilepticus
on Jun 05, 2009 Female patient from TURKEY , 67 years of age, was diagnosed with febrile neutropenia and was treated with Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: status epilepticus. Ceftazidime dosage: 6 G, Qod. During the same period patient was treated with CIPROFLOXACIN (400 Mg, Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ).

6217194-8 | Status Epilepticus
on May 26, 2009 Female patient from TURKEY , 67 years of age, was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: status epilepticus. Ceftazidime dosage: 2 G, Tid. During the same period patient was treated with CIPROFLOXACIN (200 Mg, Bid) (View Ciprofloxacin Review and Ciprofloxacin Label ).

6202068-9 | Cardio-respiratory Arrest, Extremity Contracture, Status Epilepticus, Stupor
Patient was taking Ceftazidime (View Usage). Patient had the following side effects: cardio-respiratory arrest, extremity contracture, status epilepticus, stupor on May 12, 2009 from TURKEY Additional patient health information: Female patient , 67 years of age, was diagnosed with febrile neutropenia and. Ceftazidime dosage: 2g See Dosage Text. During the same period patient was treated with CIPROFLOXACIN HCL (200mg Twice Per Day) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), HEMODIALYSIS (View Hemodialysis Review and Hemodialysis Label ).

6165046-4 | Eye Pruritus, Lacrimation Increased, Paraesthesia, Rash, Stomatitis, Urticaria
Adverse event was reported on Apr 21, 2009 by a Female patient taking Ceftazidime (View Usage) (Dosage: 2 Gm Q 12 Hours Iv Bolus) was diagnosed with condition aggravated, cystic fibrosis and. Location: UNITED STATES , 59 years of age, weighting 116.0 lb, After Ceftazidime was administered, patient had the following side effects: eye pruritus, lacrimation increased, paraesthesia, rash (What is rash?), stomatitis, urticaria.

6102143-3 | Rash Maculo-papular
on Mar 03, 2009 Female patient from UNITED STATES , weighting 105.3 lb, was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: rash maculo-papular. Ceftazidime dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

6085860-3 | Ototoxicity
on Feb 12, 2009 Female patient from UNITED KINGDOM , 74 years of age, weighting 145.5 lb, was diagnosed with osteomyelitis, arterial disorder and was treated with Ceftazidime (View Usage). Patient had the following side effects: ototoxicity. Ceftazidime dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), FLUCLOXACILLIN (2000mg Per Day) (View Flucloxacillin Review and Flucloxacillin Label ), CIPROFLOXACIN (1000mg Per Day) (View Ciprofloxacin Review and Ciprofloxacin Label ), ETODOLAC (600mg Per Day) (View Etodolac Review and Etodolac Label ), ADALAT (40mg Per Day) (View Adalat Review and Adalat Label ), CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), AMITRIPTYLINE (20mg Per Day) (View Amitriptyline Review and Amitriptyline Label ), NAFTIDROFURYL OXALATE (300mg Per Day) (View Naftidrofuryl Oxalate Review and Naftidrofuryl Oxalate Label ). Patient was hospitalized and became disabled.

5988153-5 | Dyspnoea, Hypersensitivity
Patient was taking Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: dyspnoea, hypersensitivity on Dec 08, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 164.9 lb, . Ceftazidime dosage: .

5928266-7 | Asthenia, Dyspnoea, Hyperhidrosis, Oxygen Saturation Decreased
Adverse event was reported on Oct 22, 2008 by a Female patient taking Ceftazidime (View Usage) (Dosage: 1 Gm Every 8 Hours Iv) was diagnosed with lung infection pseudomonal and. Location: UNITED STATES , 22 years of age, weighting 104.5 lb, Patient experienced the following unwanted or unexpected effects: asthenia, dyspnoea, hyperhidrosis, oxygen saturation decreased. During the same period patient was treated with CENTRUM (View Centrum Review and Centrum Label ), PANCREASE MT 16 (View Pancrease Mt-16 Review and Pancrease Mt-16 Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ESTROSTEP OCP (View Estrostep Ocp Review and Estrostep Ocp Label ), PHYTONIDIONE (View Phytonidione Review and Phytonidione Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALCIUM + D (View Calcium + D Review and Calcium + D Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

5870626-7 | Blood Creatinine Increased, C-reactive Protein Increased, Chest Discomfort, Dyspnoea, Kidney Transplant Rejection, Pleural Effusion, Pleurisy, Propionibacterium Infection, Pyrexia
on Aug 25, 2008 Male patient from ITALY , 33 years of age, was diagnosed with immunosuppression and was treated with Ceftazidime (View Usage). Patient had the following side effects: blood creatinine increased, c-reactive protein increased, chest discomfort, dyspnoea, kidney transplant rejection, pleural effusion, pleurisy, propionibacterium infection, pyrexia. Ceftazidime dosage: . During the same period patient was treated with CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), BASILIXIMAB (View Basiliximab Review and Basiliximab Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

5849166-7 | Hepatic Enzyme Increased
on Aug 18, 2008 Male patient from UNITED STATES , 22 years of age, weighting 213.8 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: hepatic enzyme increased. Ceftazidime dosage: 1 G Q8h Iv. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DUONEB (View Duoneb Review and Duoneb Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), LOVENOX (View Lovenox Review and Lovenox Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), PREVACID (View Prevacid Review and Prevacid Label ), ATIVAN (View Ativan Review and Ativan Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ).

5821474-5 | Haemolysis Neonatal
Patient was taking Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: haemolysis neonatal on Jul 16, 2008 from UNITED KINGDOM Additional patient health information: Male patient , weighting 3.46 lb, . Ceftazidime dosage: 80mg Per Day. During the same period patient was treated with VITAMIN K1 (View Vitamin K1 Review and Vitamin K1 Label ), CAFFEINE CITRATE (View Caffeine Citrate Review and Caffeine Citrate Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), FLOXACILLIN SODIUM (View Floxacillin Sodium Review and Floxacillin Sodium Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

5818768-6 | Dermatitis Exfoliative, Rash Papular
Adverse event was reported on Jul 21, 2008 by a Male patient taking Ceftazidime (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 194.7 lb, Patient had the following side effects: dermatitis exfoliative, rash papular.

5733286-1 | Haematuria, Thrombocytopenia
on May 07, 2008 Male patient from UNITED KINGDOM , 71 years of age, weighting 176.4 lb, was diagnosed with pneumonia (What is pneumonia?), chronic obstructive pulmonary disease and was treated with Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: haematuria, thrombocytopenia. Ceftazidime dosage: 3g Per Day. During the same period patient was treated with ISOSORBIDE MONONITRATE (120mg Per Day) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), DILTIAZEM (180mg Per Day) (View Diltiazem Review and Diltiazem Label ), ATORVASTATIN (40mg Per Day) (View Atorvastatin Review and Atorvastatin Label ), EZETIMIBE (10mg Per Day) (View Ezetimibe Review and Ezetimibe Label ), OMEPRAZOLE (75mg Per Day) (View Omeprazole Review and Omeprazole Label ), CARBOCYSTEINE (75mg Per Day) (View Carbocysteine Review and Carbocysteine Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), ALBUTEROL (10mg Per Day) (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5625269-7 | Blister, Blood Culture Positive, Cerebrovascular Accident, Diarrhoea, Disease Progression, Ecthyma, Endocarditis Candida, Erythema, Fungal Sepsis
on Feb 08, 2008 Female patient from SAUDI ARABIA , 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: blister, blood culture positive, cerebrovascular accident, diarrhoea, disease progression, ecthyma, endocarditis candida, erythema, fungal sepsis. Ceftazidime dosage: 1 G Hourly. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), FLUCLOXACILLIN SODIUM (FLUCLOXACILLIN) (500 Mg Every 6 Hours) (View Flucloxacillin Sodium (flucloxacillin) Review and Flucloxacillin Sodium (flucloxacillin) Label ), RIFAMPICIN (300 Mg) (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ). Patient was hospitalized.

5583065-3 | Anaphylactic Shock, Blood Pressure Immeasurable, Chest Pain, Choking Sensation, Dizziness, Foaming At Mouth, Hypoaesthesia, Pulse Absent
Patient was taking Ceftazidime (View Usage). Patient had the following side effects: anaphylactic shock, blood pressure immeasurable, chest pain (What is chest pain?), choking sensation, dizziness (What is dizziness?), foaming at mouth, hypoaesthesia, pulse absent on Dec 27, 2007 from CHINA Additional patient health information: Male patient , 56 years of age, was diagnosed with bronchitis chronic and. Ceftazidime dosage: 2g Single Dose.

5518308-5 | Condition Aggravated, Corneal Perforation, Disease Progression, Eye Excision, Hypopyon, Iris Disorder, Keratitis, Keratitis Bacterial
Adverse event was reported on Oct 29, 2007 by a Male patient taking Ceftazidime (View Usage) (Dosage: Every 30 Minutes, Topical) was diagnosed with eye infection (What is eye infection?) and. Location: UNITED KINGDOM , 25 years of age, After Ceftazidime was administered, patient had the following side effects: condition aggravated, corneal perforation, disease progression, eye excision, hypopyon, iris disorder, keratitis, keratitis bacterial. During the same period patient was treated with PENICILLIN G (Every 30 Minutes, Topical) (View Penicillin G Review and Penicillin G Label ), CIPROFLOXACIN (750 Mg, Bid, Oral) (View Ciprofloxacin Review and Ciprofloxacin Label ), NETILMICIN SULFATE (200 Mg/day) (View Netilmicin Sulfate Review and Netilmicin Sulfate Label ). Patient was hospitalized and became disabled.

5502016-0 | Arthralgia, Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Dizziness, Eosinophilia, Haematuria, Headache, Nausea
on Oct 22, 2007 Female patient from UNITED KINGDOM , 20 years of age, was diagnosed with pseudomonas infection and was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, blood creatinine increased, creatinine renal clearance decreased, dizziness (What is dizziness?), eosinophilia, haematuria, headache (What is headache?), nausea (What is nausea?). Ceftazidime dosage: 3g Three Times Per Day. During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), COLOMYCIN (View Colomycin Review and Colomycin Label ), TOBRAMYCIN (160mg Three Times Per Day) (View Tobramycin Review and Tobramycin Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

5474798-8 | Blood Creatinine Increased, Blood Urea Increased, Creatinine Renal Clearance Decreased, Eosinophilia, Haematuria, Pyrexia, Rash Macular, Renal Failure Acute
on Sep 18, 2007 Female patient from UNITED KINGDOM , 19 years of age, was treated with Ceftazidime (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, creatinine renal clearance decreased, eosinophilia, haematuria, pyrexia, rash macular, renal failure acute. Ceftazidime dosage: 3g Three Times Per Day. During the same period patient was treated with TOBRAMYCIN (120mg Three Times Per Day) (View Tobramycin Review and Tobramycin Label ), COLOMYCIN (2megu Three Times Per Day) (View Colomycin Review and Colomycin Label ).

5474797-6 | Arthralgia, Blood Creatinine Increased, Blood Pressure Increased, Blood Urea Increased, Creatinine Renal Clearance Decreased, Eosinophilia, Haematuria, Headache, Nausea
Patient was taking Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: arthralgia, blood creatinine increased, blood pressure increased, blood urea increased, creatinine renal clearance decreased, eosinophilia, haematuria, headache (What is headache?), nausea (What is nausea?) on Sep 18, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 20 years of age, . Ceftazidime dosage: 3g Three Times Per Day. During the same period patient was treated with TOBRAMYCIN (160mg Three Times Per Day) (View Tobramycin Review and Tobramycin Label ), COLOMYCIN (2megu Three Times Per Day) (View Colomycin Review and Colomycin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

5448162-1 | Renal Failure Acute
Adverse event was reported on Aug 21, 2007 by a Male patient taking Ceftazidime (View Usage) (Dosage: ) was diagnosed with antibiotic prophylaxis, bronchopulmonary aspergillosis allergic and. Location: UNITED KINGDOM , child 10 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), GENTAMICIN (9.99 Mg/kg; Intravenous (not Otherwise Specified)) (View Gentamicin Review and Gentamicin Label ).

5443419-2 | Blood Creatinine Increased, Nephritis Interstitial, Oliguria, Renal Failure Acute, Renal Tubular Necrosis
on Aug 21, 2007 Female patient from UNITED KINGDOM , child 9 years of age, was diagnosed with antibiotic prophylaxis and was treated with Ceftazidime (View Usage). Patient had the following side effects: blood creatinine increased, nephritis interstitial, oliguria, renal failure acute, renal tubular necrosis. Ceftazidime dosage: . During the same period patient was treated with GENTAMICIN (3.28mgk Three Times Per Day) (View Gentamicin Review and Gentamicin Label ), COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).

5443418-0 | Blood Creatinine Increased, Renal Failure Acute
on Aug 21, 2007 Female patient from UNITED KINGDOM , child 8 years of age, was diagnosed with antibiotic prophylaxis and was treated with Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: blood creatinine increased, renal failure acute. Ceftazidime dosage: . During the same period patient was treated with GENTAMICIN (3.33mgk Three Times Per Day) (View Gentamicin Review and Gentamicin Label ), COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).

5443417-9 | Blood Creatinine Increased, Renal Failure Acute
Patient was taking Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, renal failure acute on Aug 21, 2007 from UNITED KINGDOM Additional patient health information: Female patient , child 8 years of age, was diagnosed with antibiotic prophylaxis and. Ceftazidime dosage: . During the same period patient was treated with GENTAMICIN (3.7mgk Three Times Per Day) (View Gentamicin Review and Gentamicin Label ), COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).

5443416-7 | Anuria, Blood Creatinine Increased, Renal Failure Acute
Adverse event was reported on Aug 21, 2007 by a Male patient taking Ceftazidime (View Usage) (Dosage: ) was diagnosed with antibiotic prophylaxis and. Location: UNITED KINGDOM , child 4 years of age, Patient had the following side effects: anuria, blood creatinine increased, renal failure acute. During the same period patient was treated with GENTAMICIN (3.98mgk Three Times Per Day) (View Gentamicin Review and Gentamicin Label ), COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).

5443415-5 | Blood Creatinine Increased, Oliguria, Renal Failure Acute, Renal Tubular Necrosis
on Aug 21, 2007 Male patient from UNITED KINGDOM , child 7 years of age, was diagnosed with antibiotic prophylaxis and was treated with Ceftazidime (View Usage). After Ceftazidime was administered, patient had the following side effects: blood creatinine increased, oliguria, renal failure acute, renal tubular necrosis. Ceftazidime dosage: . During the same period patient was treated with GENTAMICIN (4.16mgk Three Times Per Day) (View Gentamicin Review and Gentamicin Label ), COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).

5443414-3 | Anuria, Blood Creatinine Increased, Deafness Neurosensory, Kidney Enlargement, Renal Failure Acute
on Aug 21, 2007 Male patient from UNITED KINGDOM , child 4 years of age, was diagnosed with antibiotic prophylaxis and was treated with Ceftazidime (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, blood creatinine increased, deafness neurosensory, kidney enlargement, renal failure acute. Ceftazidime dosage: . During the same period patient was treated with GENTAMICIN (5.16mgk Three Times Per Day) (View Gentamicin Review and Gentamicin Label ), COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).

5443413-1 | Blood Creatinine Increased, Renal Failure Acute
Patient was taking Ceftazidime (View Usage). Patient had the following side effects: blood creatinine increased, renal failure acute on Aug 21, 2007 from UNITED KINGDOM Additional patient health information: Male patient , child 10 years of age, was diagnosed with antibiotic prophylaxis, bronchopulmonary aspergillosis allergic and. Ceftazidime dosage: . During the same period patient was treated with GENTAMICIN (3.33mgk Three Times Per Day) (View Gentamicin Review and Gentamicin Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).